Antiretroviral drug class exposure during 36 months of follow-up.

Distribution of participants exposed to each major ART class, including nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors, integrase strand transfer inhibitors, and CCR5 inhibitors. Exposure is categorized as remained on therapy throughout, discontinued, or never exposed during the 36-month follow-up period. Data are provided as a CSV file and archived in Figshare (DOI: 10.6084/m9.figshare.30032515). (XLSX)